Literature DB >> 9382062

Plasma adrenomedullin levels in patients with hepatic cirrhosis.

E Fábrega1, F Casafont, J Crespo, J de la Peña, G San Miguel, G de las Heras, M T García-Unzueta, J A Amado, F Pons-Romero.   

Abstract

OBJECTIVE: The role of adrenomedullin in cirrhosis is at present unknown. The aim of this study was to investigate plasma levels of adrenomedullin in cirrhosis.
METHODS: We measured plasma adrenomedullin concentrations using radioimmunoassay in 43 patients with cirrhosis (17 in Child-Pugh's class A, 13 in Child-Pugh's class B, and 13 in Child-Pugh's class C) and compared these values with those in 24 age-matched healthy subjects. Renal function, plasma cyclic adenosine monophosphate (cAMP) concentration, plasma renin activity, and plasma aldosterone concentration were measured in each patient.
RESULTS: Plasma adrenomedullin levels were increased significantly in patients with cirrhosis compared with healthy subjects. In addition, plasma adrenomedullin values were higher in patients with cirrhosis and ascites than in those without ascites. Moreover, plasma adrenomedullin levels increased in relation to the severity of cirrhosis. Significant positive correlations also were found between adrenomedullin and cAMP concentrations and plasma renin activity or plasma aldosterone concentrations.
CONCLUSIONS: Plasma adrenomedullin is increased in patients with cirrhosis compared with healthy subjects. The increase in plasma adrenomedullin levels is related at least in part to the severity of cirrhosis and may contribute to the arteriolar vasodilation in patients with cirrhosis. These effects are related in part to a cAMP-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382062

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Parathyroid hormone-related protein in liver cirrhosis.

Authors:  E Fabrega; M Rivero; F Pons-Romero; M T García-Unzueta; J A Amado
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

Review 2.  New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure.

Authors:  Francisco Valenzuela-Sánchez; Blanca Valenzuela-Méndez; Juan Francisco Rodríguez-Gutiérrez; Ángel Estella-García; María Ángela González-García
Journal:  Ann Transl Med       Date:  2016-09

3.  Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide.

Authors:  J Genesca; A Gonzalez; R Catalan; R Segura; M Martinez; R Esteban; R J Groszmann; J Guardia
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

4.  Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.

Authors:  V Tahan; E Avsar; C Karaca; E Uslu; F Eren; S Aydin; H Uzun; H O Hamzaoglu; F Besisik; C Kalayci; A Okten; N Tozun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 5.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes.

Authors:  Bryan L Copple; Juan J Bustamante; Timothy P Welch; Nam Deuk Kim; Jeon-Ok Moon
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.